Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6715123rdf:typepubmed:Citationlld:pubmed
pubmed-article:6715123lifeskim:mentionsumls-concept:C0034493lld:lifeskim
pubmed-article:6715123lifeskim:mentionsumls-concept:C0878544lld:lifeskim
pubmed-article:6715123lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:6715123lifeskim:mentionsumls-concept:C0087163lld:lifeskim
pubmed-article:6715123pubmed:issue1lld:pubmed
pubmed-article:6715123pubmed:dateCreated1984-6-1lld:pubmed
pubmed-article:6715123pubmed:abstractTextThe authors conducted an investigation in order to ascertain whether or not L-carnitine, by promoting the utilization of FFA for energy and neutralizing FFA toxicity occurring after ischaemia, could prevent or confine adriamycin-induced cardiotoxicity in rabbits. The results show that L-carnitine determines a higher survival rate and reduced onset of cardiomyopathy. Histopathological examination of myocardial tissue under light and electron microscopy revealed a marked decrease in mitochondrial lesions.lld:pubmed
pubmed-article:6715123pubmed:languageenglld:pubmed
pubmed-article:6715123pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6715123pubmed:citationSubsetIMlld:pubmed
pubmed-article:6715123pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6715123pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6715123pubmed:statusMEDLINElld:pubmed
pubmed-article:6715123pubmed:issn0250-0868lld:pubmed
pubmed-article:6715123pubmed:authorpubmed-author:ParisiGGlld:pubmed
pubmed-article:6715123pubmed:authorpubmed-author:CarrecaIIlld:pubmed
pubmed-article:6715123pubmed:authorpubmed-author:CampisiDDlld:pubmed
pubmed-article:6715123pubmed:authorpubmed-author:FuritanoGGlld:pubmed
pubmed-article:6715123pubmed:authorpubmed-author:ScaffidiLLlld:pubmed
pubmed-article:6715123pubmed:authorpubmed-author:PaternaSSlld:pubmed
pubmed-article:6715123pubmed:authorpubmed-author:BarbarinoCClld:pubmed
pubmed-article:6715123pubmed:issnTypePrintlld:pubmed
pubmed-article:6715123pubmed:volume6lld:pubmed
pubmed-article:6715123pubmed:ownerNLMlld:pubmed
pubmed-article:6715123pubmed:authorsCompleteYlld:pubmed
pubmed-article:6715123pubmed:pagination91-5lld:pubmed
pubmed-article:6715123pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6715123pubmed:meshHeadingpubmed-meshheading:6715123-...lld:pubmed
pubmed-article:6715123pubmed:meshHeadingpubmed-meshheading:6715123-...lld:pubmed
pubmed-article:6715123pubmed:meshHeadingpubmed-meshheading:6715123-...lld:pubmed
pubmed-article:6715123pubmed:meshHeadingpubmed-meshheading:6715123-...lld:pubmed
pubmed-article:6715123pubmed:meshHeadingpubmed-meshheading:6715123-...lld:pubmed
pubmed-article:6715123pubmed:meshHeadingpubmed-meshheading:6715123-...lld:pubmed
pubmed-article:6715123pubmed:meshHeadingpubmed-meshheading:6715123-...lld:pubmed
pubmed-article:6715123pubmed:meshHeadingpubmed-meshheading:6715123-...lld:pubmed
pubmed-article:6715123pubmed:year1984lld:pubmed
pubmed-article:6715123pubmed:articleTitleEffects of L-carnitine on adriamycin-induced cardiomyopathy in rabbit.lld:pubmed
pubmed-article:6715123pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6715123pubmed:publicationTypeComparative Studylld:pubmed